about
Loss of UCP2 attenuates mitochondrial dysfunction without altering ROS production and uncoupling activityLactosylceramide contributes to mitochondrial dysfunction in diabetesTriglycerides in the human kidney cortex: relationship with body sizeMyocardial Structural and Biological Anomalies Induced by High Fat Diet in Psammomys obesus GerbilsCardiomyocyte-specific perilipin 5 overexpression leads to myocardial steatosis and modest cardiac dysfunctionInsulin Signaling and Heart Failure.Phospholipid homeostasis and lipotoxic cardiomyopathy: a matter of balance.Cancer induces cardiomyocyte remodeling and hypoinnervation in the left ventricle of the mouse heart(1)H-MR spectroscopy for analysis of cardiac lipid and creatine metabolism.Myocardial triglyceride content at 3 T cardiovascular magnetic resonance and left ventricular systolic function: a cross-sectional study in patients hospitalized with acute heart failure.Post-translational modifications of the cardiac proteome in diabetes and heart failureMetabolic and Biochemical Stressors in Diabetic Cardiomyopathy.Rescue of cardiac leptin receptors in db/db mice prevents myocardial triglyceride accumulationDiabetic cardiomyopathy, causes and effects.Acetyl-L-carnitine supplementation reverses the age-related decline in carnitine palmitoyltransferase 1 (CPT1) activity in interfibrillar mitochondria without changing the L-carnitine content in the rat heartRelationships between body fat distribution, epicardial fat and obstructive sleep apnea in obese patients with and without metabolic syndrome.Protective effects of Acyl-coA thioesterase 1 on diabetic heart via PPARα/PGC1α signaling.Effects of insulin therapy on myocardial lipid content and cardiac geometry in patients with type-2 diabetes mellitus.Effects of coronary ischemia-reperfusion in a rat model of early overnutrition. Role of angiotensin receptors.Mechanisms of heart failure in obesity.Cardiac function and lipid distribution in rats fed a high-fat diet: in vivo magnetic resonance imaging and spectroscopy.Cardiomyocyte lipids impair β-adrenergic receptor function via PKC activation.Reversible high affinity inhibition of phosphofructokinase-1 by acyl-CoA: a mechanism integrating glycolytic flux with lipid metabolism.Modulating fatty acid oxidation in heart failure.Renal lipid metabolism and lipotoxicity.Caloric excess or restriction mediated modulation of metabolic enzyme acetylation-proposed effects on cardiac growth and function.Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy.Cardiac steatosis potentiates angiotensin II effects in the heart.Lipid-induced NOX2 activation inhibits autophagic flux by impairing lysosomal enzyme activityReversible Cardiomyopathies.The Metabolome in Finnish Carriers of the MYBPC3-Q1061X Mutation for Hypertrophic Cardiomyopathy.Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice.Enhancing Cardiac Triacylglycerol Metabolism Improves Recovery From Ischemic Stress.Pericardial- Rather than Intramyocardial Fat Is Independently Associated with Left Ventricular Systolic Heart Function in Metabolically Healthy Humans.Unsticking the Broken Diabetic Heart: O-GlcNAcylation and Calcium Sensitivity.Effects of diet and development on the Drosophila lipidomeVentricular late potential in cardiac syndrome X compared to coronary artery disease.Increased Epicardial Adipose Tissue Thickness in Type 2 Diabetes Mellitus and ObesityMetabolic stress in the myocardium: adaptations of gene expression.Mechanisms of lipotoxicity in the cardiovascular system.
P2860
Q27315724-11A28B53-B034-418C-BF3C-406ED8C93758Q28390671-4CF1F83A-E5EF-4E48-B19A-E0142166CB43Q28542644-23B65401-950D-4ECC-9071-D0CAF254F582Q28553085-131AC61A-2C1F-4579-88E1-323727659CB4Q28589187-23EA0AC7-96A9-4D1D-B3A3-2D0B8A874AF0Q30377910-2100C3EB-E503-4CB2-B822-0CDE44010045Q30401856-56722A3C-4EC2-4F86-BD78-8A18099627BEQ30475241-535740CA-9908-4149-80A6-723AA1A17F7DQ30560950-A567B1C2-8202-4928-BE82-B689BB3E49EAQ31043315-90D7AE96-7E2B-41BE-AB45-F2E05CAC6E68Q33361067-F0DD7B46-2777-48F8-9C59-D70187D09F1BQ33740554-AF1D682F-B5A4-454D-98E2-16F17D79571BQ34001340-247DBC89-4013-4D19-852F-A8307291CFC7Q34038623-4F765DC2-0F1E-45FD-B933-995AD8B4E652Q34102948-30445235-2095-4DD1-8C5B-8260329A1647Q34442792-EF75434C-2A73-43BE-8144-D9B59DEF5933Q34505302-D149EBB4-3E7E-4F34-8F0C-64DF9095F8B5Q34506453-89A479F2-42FF-4C71-B845-27FF7A04F5FCQ34577046-A5D1C875-54C5-4933-9826-6A61F6716D8AQ34606458-EA3B96EB-ADC2-463F-B92D-EFFB4A353C92Q34642852-4871569C-03B9-4D4F-8F80-8C8DA38EEFFAQ34718192-6497BF2D-2C93-4E0A-916F-3E0CDA7EEC1EQ34752001-C57C1794-E27A-431F-890A-AE56F799EB4DQ34808505-E16DFF33-CD7C-4709-8818-1AB8CA060ED6Q34825296-417AF9FD-4F42-4793-A641-E4B100719C1AQ35028393-6794ACC8-AF50-4A73-AA52-2502F2AB762CQ35045900-BD4DF081-CAEC-4E0A-8166-A2F5DE2E69AAQ35086438-50C85697-5E76-4D41-A00C-65CCBE03E94BQ35120903-3B04A665-6316-4733-989F-25EBAD239240Q35636735-33852C1F-540A-4CB6-B116-9590175313B5Q35743765-D38BEC3C-ED15-40A6-8256-3574E0CBED76Q35780290-3B64D399-29FE-4753-A5D2-8BD47CAA2FBAQ35881763-6AABC55C-ECA3-4EEB-8CBD-EB70175E02AAQ35953956-3C19B69B-33B3-4E3B-B17B-2A60ED8E84A9Q36104623-35C63967-3D33-466B-AF15-46E62CFFA6ECQ36171156-C1B7C95C-48DD-408B-845A-D88C5160DE3EQ36254321-2C2A0BA5-5B47-463A-9910-7CAD4BD3063CQ36271979-AD761122-5DF2-42AC-BD48-CEB6963EEAE9Q36328486-CF6513CC-9807-4D1A-AEA5-C8BD1B6D0E23Q36377252-AA6045B8-0A09-4B5A-9EFF-74D89A193DD4
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Lipotoxicity in the heart.
@ast
Lipotoxicity in the heart.
@en
type
label
Lipotoxicity in the heart.
@ast
Lipotoxicity in the heart.
@en
prefLabel
Lipotoxicity in the heart.
@ast
Lipotoxicity in the heart.
@en
P2860
P1476
Lipotoxicity in the heart.
@en
P2093
Adam R Wende
E Dale Abel
P2860
P304
P356
10.1016/J.BBALIP.2009.09.023
P407
P577
2009-10-08T00:00:00Z